Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joe Y Chang

Showing results (131-140 of 312) with videos related to

Pageof 32
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinomaLiru He, Pamela K Allen, Adam Potter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Surgical patterns of care in operable lung carcinoma treated with radiationJoe Y Chang, Jennifer Moughan, David W Johnstone, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomographyKeith R Britton, George Starkschall, Susan L Tucker, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2010
Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapyJames Welsh, Jimmy Thomas, Deep Shah, et al.
Practical Radiation Oncology|October 17, 2016
Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicityWilliam W Chance, Quynh-Nhu Nguyen, Reza Mehran, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictorsDaniel R Gomez, Falk Poenisch, Chelsea C Pinnix, et al.
Cancer|January 26, 2011
Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancerSamir Sejpal, Ritsuko Komaki, Anne Tsao, et al.
Oncology Reports|April 22, 2008
Effect of combining anti-epidermal growth factor receptor antibody C225 and radiation on DU145 prostate cancerMatthew Wagener, Xiaochun Zhang, Humberto G Villarreal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 17, 2020
An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancerChonnipa Nantavithya, Daniel R Gomez, Joe Y Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|August 21, 2012
Automated volumetric modulated Arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy?Enzhuo M Quan, Joe Y Chang, Zhongxing Liao, et al.
Pageof 32

Showing results (131-140 of 312) with videos related to

Sort By:
Pageof 32
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Re-evaluating the optimal radiation dose for definitive chemoradiotherapy for esophageal squamous cell carcinomaLiru He, Pamela K Allen, Adam Potter, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
Surgical patterns of care in operable lung carcinoma treated with radiationJoe Y Chang, Jennifer Moughan, David W Johnstone, et al.
International Journal of Radiation Oncology, Biology, Physics|March 24, 2007
Assessment of gross tumor volume regression and motion changes during radiotherapy for non-small-cell lung cancer as measured by four-dimensional computed tomographyKeith R Britton, George Starkschall, Susan L Tucker, et al.
International Journal of Radiation Oncology, Biology, Physics|June 15, 2010
Obesity increases the risk of chest wall pain from thoracic stereotactic body radiation therapyJames Welsh, Jimmy Thomas, Deep Shah, et al.
Practical Radiation Oncology|October 17, 2016
Stereotactic ablative radiotherapy for adrenal gland metastases: Factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicityWilliam W Chance, Quynh-Nhu Nguyen, Reza Mehran, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 2013
Malfunctions of implantable cardiac devices in patients receiving proton beam therapy: incidence and predictorsDaniel R Gomez, Falk Poenisch, Chelsea C Pinnix, et al.
Cancer|January 26, 2011
Early findings on toxicity of proton beam therapy with concurrent chemotherapy for nonsmall cell lung cancerSamir Sejpal, Ritsuko Komaki, Anne Tsao, et al.
Oncology Reports|April 22, 2008
Effect of combining anti-epidermal growth factor receptor antibody C225 and radiation on DU145 prostate cancerMatthew Wagener, Xiaochun Zhang, Humberto G Villarreal, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 17, 2020
An improved method for analyzing and reporting patterns of in-field recurrence after stereotactic ablative radiotherapy in early-stage non-small cell lung cancerChonnipa Nantavithya, Daniel R Gomez, Joe Y Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|August 21, 2012
Automated volumetric modulated Arc therapy treatment planning for stage III lung cancer: how does it compare with intensity-modulated radio therapy?Enzhuo M Quan, Joe Y Chang, Zhongxing Liao, et al.
Pageof 32